[1] JAUNIAUX E,D'ANTONIO F,BHIDE A,et al.Modified Delphi study of ultrasound signs associated with placenta accretaspectrum[J].Ultrasound Obstet Gynecol,2023,61(4):518-525.
[2] SENTILHES L,KAYEM G,CHANDRAHARAN E,et al.FIGO consensus guidelines on placenta accreta spectrum disorders:conservative management[J].Int J Gynaecol Obstet, 2018,140(3):291-298.
[3] MING Y H,ZENG X J,ZHENG T,et al.Epidemiology of placentaaccreta spectrum disorders in Chinese pregnant women: a multicenter hospital-based study[J].Placenta,2022,126:133-139.
[4] SHAHIN Y,PANG C L.Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis[J].Eur Radiol,2018,28(7):2713-2726.
[5] TINARI S,BUCA D,CALI G,et al.Risk factors,histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis[J].Ultrasound Obstet Gynecol,2021,57(6):903-909.
[6] 曾琴燕,董湘梅,魏青文.胎盘植入发生的相关危险因素及其妊娠结局分析[J].现代诊断与治疗,2022,33(8):1214-1216.
[7] THURN L,LINDQVIST P G,JAKOBSSON M,et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries[J].BJOG,2016,123(8):1348-1355.
[8] ESHKOLI T,WEINTRAUB A Y,SERGIENKO R,et al.Placenta accreta:risk factors,perinatal outcomes,and consequences for subsequent births[J].Am J Obstet Gynecol,2013,208(3):219.e1-219.e7.
[9] HECHT J L,BAERGEN R,ERNST L M, et al.Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum(pas) disorders: recommendations from an expert panel[J].Mod Pathol,2020,33(12):2382-2396.
[10] COLLINS S L,ALEMDAR B,VAN BEEKHUIZEN H J,et al.Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the international society for abnormally invasive placenta[J].Am J Obstet Gynecol,2019,220(6):511-526.
[11] 张洁莹,万辉,谌海娟,等.超声在诊治胎盘植入中的应用现状与进展[J].影像科学与光化学,2022,40(2):220-224.
[12] 李泽丽,陈练,赵扬玉.分子标志物在胎盘植入性疾病产前诊断中的应用价值[J].中国实用妇科与产科杂志,2021,37(11):1105-1108.
[13] JAUNIAUX E,ALFIREVIC Z,BHIDE A G,et al.Placenta praevia and placenta accreta:diagnosis and management:green-top guideline no. 27a[J].BJOG,2019,126(1):e1-e48.
[14] JAUNIAUX E, AYRES-DE-CAMPOS D.FIGO consensus guidelines on placenta accreta spectrum disorders: introduction[J].Int J Gynaecol Obstet,2018,140(3):261-264.
[15] 陈敦金,杨慧霞.胎盘植入诊治指南(2015)[J].中华产科急救电子杂志,2016,5(1):26-31.
[16] JAUNIAUX E,BHIDE A,KENNEDY A, et al.FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening[J].Int J Gynaecol Obstet, 2018,140(3):274-280.
[17] JAUNIAUX E,CHANTRAINE F,SILVER R M,et al.FIGO consensus guidelines on placenta accreta spectrum disorders:epidemiology[J].Int J Gynaecol Obstet,2018,140(3):265-273.
[18] KUTUK M S, AK M, OZGUN M T.Leaving the placenta in situ versus conservative and radical surgery in the treatment of placenta accreta spectrum disorders[J].Int J Gynaecol Obstet,2018,140(3):338-344.
[19] OVERTON E, BOOKER W A, MOURAD M, et al. Prophylactic endovascular internal iliac balloon placement during cesarean hysterectomy for placenta accreta spectrum[J].Am J Obstet Gynecol MFM,2022,4(5):100657.
[20] ALLEN L, JAUNIAUX E, HOBSON S,et al.FIGO consensus guidelines on placenta accreta spectrum disorders:nonconservative surgical management[J].Int J Gynaecol Obstet,2018,140(3):281-290.
[21] PETTERSEN S, FALK R S, VANGEN S,et al.Peripartum hysterectomy due to severe postpartum hemorrhage:a hospital-based study[J].Acta Obstet Gynecol Scand,2022,101(7):819-826.
[22] ALAM B,NASIR F,AKBARI A R,et al.A review and comparison of the efficacy of prophylactic interventional radiological arterial occlusions in placenta accreta spectrum patients:a meta-analysis[J].Acad Radiol,2023,30(7):1443-1455.
[23] ZUCKERWISE L C,CRAIG A M,NEWTON J M,et al.Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum[J].Am J Obstet Gynecol,2020,222(2):179.e1-179.e9.
[24] MUNOZ J L,BLANKENSHIP L M,RAMSEY P S,et al.Implementation and outcomes of a uterine artery embolization and tranexamic acid protocol for placenta accreta spectrum[J].Am J Obstet Gynecol,2023,229(1):61.e1-61.e7.
[25] SCAGLIONE M A,ALLSHOUSE A A,CANFIELD D R,et al.Prophylactic ureteral stent placement and urinary injury during hysterectomy for placenta accreta spectrum[J].Obstet Gynecol,2022,140(5):806-811.
[26] PINELES B L,SIBAI B M, SENTILHES L.Is conservative management of placenta accreta spectrum disorders practical in the united states?[J].Am J Obstet Gynecol MFM,2023,5(3):100749.
[27] YUAN Y,HE X,LIU P,et al.The effectiveness of single ultrasound-guided high-intensity focused ultrasound(USGHIFU) ablation in managing placenta accreta spectrum(PAS) disorder[J].Arch Gynecol Obstet,2023,307(4):1037-1045.
[28] ABD ELAZEEM H A S,SAAD M M,AHMED I A,et al.High-intensity focused ultrasound in management of placenta accreta spectrum:a systematic review[J].Int J Gynaecol Obstet,2020,151(3):325-332.
[29] FLORES-MENDOZA H,CHANDRAN A R,HERNANDEZ-NIETO C,et al.Outcomes in emergency versus electively scheduled cases of placenta accreta spectrum disorder managed by cesarean-hysterectomy within a multidisciplinary care team[J].Int J Gynaecol Obstet,2022,159(2):404-411.
[30] PAPILLON-SMITH J,HOBSON S,ALLEN L,et al.Prophylactic internal iliac artery ligation versus balloon occlusion for placenta accreta spectrum disorders:a retrospective cohort study[J].Int J Gynaecol Obstet,2020,151(1):91-96.
[31] SHAINKER S A,ZUCKERWISE L C,SHAMSHIRSAZ A A.Conservative management of placenta accreta spectrum: is it time?[J].Am J Obstet Gynecol,2022,226(6):871.
[32] GUO Z,YANG H,MA J.Maternal circulating biomarkers associated with placenta accreta spectrum disorders[J].Chin Med J(Engl),2023,136(8):995-997.
[33] KINGDOM J C,HOBSON S R,MURJI A,et al.Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020[J].Am J Obstet Gynecol,2020,223(3):322-329.
[34] 胡燕,钱惠勤,季璇,等.多学科协作诊疗模式在救治凶险性前置胎盘中的应用[J].东南大学学报(医学版),2021,40(3):330-334.
[35] YAO R,NGUYEN H Y,HONG L,et al.Regional multidisciplinary team approach to the management of placenta accreta spectrum disorder[J].J Matern Fetal Neonatal Med,2023,36(1):2190840. |
